A Connectionist Network Approach to Psychological Science: Core and Corollary Principles

Warren W. Tryon

doi:10.1037/a0027135

A pragmatist philosophy of psychological science and its implications for replication

Behavioral and Brain Sciences ◽

10.1017/s0140525x18000626 ◽

2018 ◽

Vol 41 ◽

Cited By ~ 3

Author(s):

Ana Gantman ◽

Robin Gomila ◽

Joel E. Martinez ◽

J. Nathan Matias ◽

Elizabeth Levy Paluck ◽

...

Keyword(s):

William James ◽

Mental Processes ◽

Psychological Science ◽

Behavioral Measurement ◽

The World ◽

Pragmatist Philosophy

AbstractA pragmatist philosophy of psychological science offers to the direct replication debate concrete recommendations and novel benefits that are not discussed in Zwaan et al. This philosophy guides our work as field experimentalists interested in behavioral measurement. Furthermore, all psychologists can relate to its ultimate aim set out by William James: to study mental processes that provide explanations for why people behave as they do in the world.

Download Full-text

Replications can cause distorted belief in scientific progress

Behavioral and Brain Sciences ◽

10.1017/s0140525x18000584 ◽

2018 ◽

Vol 41 ◽

Cited By ~ 2

Author(s):

Michał Białek

Keyword(s):

Real World ◽

Scientific Progress ◽

The Public ◽

Psychological Science

AbstractIf we want psychological science to have a meaningful real-world impact, it has to be trusted by the public. Scientific progress is noisy; accordingly, replications sometimes fail even for true findings. We need to communicate the acceptability of uncertainty to the public and our peers, to prevent psychology from being perceived as having nothing to say about reality.

Download Full-text

The Collaborative Network Approach: a model for advancing patient-centric research for Castleman disease and other rare diseases

Emerging Topics in Life Sciences ◽

10.1042/etls20180178 ◽

2019 ◽

Vol 3 (1) ◽

pp. 97-105

Author(s):

Mary Zuccato ◽

Dustin Shilling ◽

David C. Fajgenbaum

Keyword(s):

Rare Diseases ◽

Treatment Options ◽

Castleman Disease ◽

High Impact ◽

Collaborative Network ◽

Network Approach ◽

Grant Applications ◽

Research Questions ◽

Novel Strategy ◽

Patient Centric

Abstract There are ∼7000 rare diseases affecting 30 000 000 individuals in the U.S.A. 95% of these rare diseases do not have a single Food and Drug Administration-approved therapy. Relatively, limited progress has been made to develop new or repurpose existing therapies for these disorders, in part because traditional funding models are not as effective when applied to rare diseases. Due to the suboptimal research infrastructure and treatment options for Castleman disease, the Castleman Disease Collaborative Network (CDCN), founded in 2012, spearheaded a novel strategy for advancing biomedical research, the ‘Collaborative Network Approach’. At its heart, the Collaborative Network Approach leverages and integrates the entire community of stakeholders — patients, physicians and researchers — to identify and prioritize high-impact research questions. It then recruits the most qualified researchers to conduct these studies. In parallel, patients are empowered to fight back by supporting research through fundraising and providing their biospecimens and clinical data. This approach democratizes research, allowing the entire community to identify the most clinically relevant and pressing questions; any idea can be translated into a study rather than limiting research to the ideas proposed by researchers in grant applications. Preliminary results from the CDCN and other organizations that have followed its Collaborative Network Approach suggest that this model is generalizable across rare diseases.

Download Full-text

Values in Psychological Science

10.1017/9781316471302 ◽

2018 ◽

Cited By ~ 1

Author(s):

Lisa Osbeck

Keyword(s):

Psychological Science

Download Full-text

Translocation Relative to Range

Methodology ◽

10.1027/1614-2241.4.3.132 ◽

2008 ◽

Vol 4 (3) ◽

pp. 132-138 ◽

Cited By ~ 3

Author(s):

Michael Höfler

Keyword(s):

Risk Difference ◽

Binary Outcomes ◽

Number Needed To Treat ◽

Likert Scales ◽

Psychological Science ◽

The Absolute ◽

The Difference ◽

Variance Parameters ◽

Standardized Index ◽

Maximum Possible Magnitude

A standardized index for effect intensity, the translocation relative to range (TRR), is discussed. TRR is defined as the difference between the expectations of an outcome under two conditions (the absolute increment) divided by the maximum possible amount for that difference. TRR measures the shift caused by a factor relative to the maximum possible magnitude of that shift. For binary outcomes, TRR simply equals the risk difference, also known as the inverse number needed to treat. TRR ranges from –1 to 1 but is – unlike a correlation coefficient – a measure for effect intensity, because it does not rely on variance parameters in a certain population as do effect size measures (e.g., correlations, Cohens d). However, the use of TRR is restricted on outcomes with fixed and meaningful endpoints given, for instance, for meaningful psychological questionnaires or Likert scales. The use of TRR vs. Cohens d is illustrated with three examples from Psychological Science 2006 (issues 5 through 8). It is argued that, whenever TRR applies, it should complement Cohens d to avoid the problems related to the latter. In any case, the absolute increment should complement d.

Download Full-text